Difference between revisions of "Oncometabolite"

From Libre Pathology
Jump to navigation Jump to search
(created)
 
(→‎Examples: wikify)
Line 12: Line 12:
|  [[Astrocytoma]], [[Oligodendroglioma]]<ref>{{Cite journal  | last1 = Hartmann | first1 = C. | last2 = Hentschel | first2 = B. | last3 = Wick | first3 = W. | last4 = Capper | first4 = D. | last5 = Felsberg | first5 = J. | last6 = Simon | first6 = M. | last7 = Westphal | first7 = M. | last8 = Schackert | first8 = G. | last9 = Meyermann | first9 = R. | title = Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas. | journal = Acta Neuropathol | volume = 120 | issue = 6 | pages = 707-18 | month = Dec | year = 2010 | doi = 10.1007/s00401-010-0781-z | PMID = 21088844 }}</ref>
|  [[Astrocytoma]], [[Oligodendroglioma]]<ref>{{Cite journal  | last1 = Hartmann | first1 = C. | last2 = Hentschel | first2 = B. | last3 = Wick | first3 = W. | last4 = Capper | first4 = D. | last5 = Felsberg | first5 = J. | last6 = Simon | first6 = M. | last7 = Westphal | first7 = M. | last8 = Schackert | first8 = G. | last9 = Meyermann | first9 = R. | title = Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas. | journal = Acta Neuropathol | volume = 120 | issue = 6 | pages = 707-18 | month = Dec | year = 2010 | doi = 10.1007/s00401-010-0781-z | PMID = 21088844 }}</ref>
|-
|-
| SDH
| [[SDH]]
| [[Paraganglioma]]<ref>{{Cite journal  | last1 = Baysal | first1 = BE. | last2 = Ferrell | first2 = RE. | last3 = Willett-Brozick | first3 = JE. | last4 = Lawrence | first4 = EC. | last5 = Myssiorek | first5 = D. | last6 = Bosch | first6 = A. | last7 = van der Mey | first7 = A. | last8 = Taschner | first8 = PE. | last9 = Rubinstein | first9 = WS. | title = Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. | journal = Science | volume = 287 | issue = 5454 | pages = 848-51 | month = Feb | year = 2000 | doi =  | PMID = 10657297 }}</ref>
| [[Paraganglioma]]<ref>{{Cite journal  | last1 = Baysal | first1 = BE. | last2 = Ferrell | first2 = RE. | last3 = Willett-Brozick | first3 = JE. | last4 = Lawrence | first4 = EC. | last5 = Myssiorek | first5 = D. | last6 = Bosch | first6 = A. | last7 = van der Mey | first7 = A. | last8 = Taschner | first8 = PE. | last9 = Rubinstein | first9 = WS. | title = Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. | journal = Science | volume = 287 | issue = 5454 | pages = 848-51 | month = Feb | year = 2000 | doi =  | PMID = 10657297 }}</ref>
|}
|}

Revision as of 18:06, 22 March 2017

An oncometabolite is a cancer associated protein, often a mutated enzyme.

Examples

Gene Cancer
fumarate hydratase (FH) Leiomyoma[1]
isocitrate dehydrogenase (IDH) Astrocytoma, Oligodendroglioma[2]
SDH Paraganglioma[3]

See also

References

  1. Yang, M.; Soga, T.; Pollard, PJ.; Adam, J. (2012). "The emerging role of fumarate as an oncometabolite.". Front Oncol 2: 85. doi:10.3389/fonc.2012.00085. PMID 22866264.
  2. Hartmann, C.; Hentschel, B.; Wick, W.; Capper, D.; Felsberg, J.; Simon, M.; Westphal, M.; Schackert, G. et al. (Dec 2010). "Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas.". Acta Neuropathol 120 (6): 707-18. doi:10.1007/s00401-010-0781-z. PMID 21088844.
  3. Baysal, BE.; Ferrell, RE.; Willett-Brozick, JE.; Lawrence, EC.; Myssiorek, D.; Bosch, A.; van der Mey, A.; Taschner, PE. et al. (Feb 2000). "Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma.". Science 287 (5454): 848-51. PMID 10657297.